Beach Boys frontman Mike Love facing ‘serious health challenges’ but insists on being on-stage - Nine.com.au
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Beach Boys frontman Mike Love is facing a serious health battle but is determined to keep performing, his close friend John Stamos has revealed. In a statement, actor and musician Stamos said that Love, 85, is being “urged to focus on his health” in a worrying update shared with fans. Stamos is currently on tour with the band. John Stamos shares worrying health update about Beach Boys lead singer Mike Love. Instagram/@johnstamos“I’m... struggling to put my feelings into words,” wrote Stamos, 63, in a joint Instagram post shared with Love’s account on Monday. “My beloved friend, father figure, musical hero and mentor, Mike Love, is facing serious health challenges. We hope he’ll be doing what he loves for years to come, but we don’t know what the future holds. We have tonight. “Mike is a fighter. Despite doctors, family and friends urging him to focus on his health, he insists on being on stage. “He says he needs his band, the audience, his friends and drummer surrounding him to lift him up.”Stamos revealed he was boarding a plane to Nashville to perform with the Good Vibrations hit makers amid the Beach Boys reunion tour.
This article is an excerpt. To read the full content, visit the original source. Nine.com.au
Related articles
David Surkamp, Pavlov’s Dog frontman, dead at 73 - Global News
David Surkamp, frontman of progressive rock band Pavlov’s Dog, has died at the age of 73. The band announced the news in a post on social media, writing, “It is with the heaviest of hearts that we share the unexpected passing of our creative force, lead singer, and dear friend, David Surkamp, on October 13.”Pavlov’s Dog bandmember Abbie Steiling said that Surkamp leaves behind a legacy of “endless creativity, unmistakable artistry, and a body of music that has touched lives across generations and around the world.”“But anyone who knew and loved him knows that his legacy reaches far beyond the songs. David had a profoundly poetic spirit and a romantic heart that found its way into every note, every lyric, and every performance,” Steiling added. “His music was deeply emotive, reaching straight into the hearts of listeners, giving voice to longing, to love, to beauty, and to the bittersweet ache of it all,” Steiling continued. Story continues below advertisement
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!